Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Semaglutide is approved by the US Food and Drug Administration (FDA) for the management of obesity under the brand name Wegovy with a reported average of 14.9% weight loss
Addressing the underlying cause may involve changes in diet, lifestyle modifications, or medical interventions
While its difficult to quantify many of these, the chart below identifies and describes many of these strategies
Putting it all together: your personalized dosing decision After absorbing all of this information, here is how to synthesize it into a practical dosing plan for your specific situation
US$ 21.05
US$ 24.25
US$ 21.48
